Key Takeaways
-
62.8% of women showed photographic improvement — nearly four times o improvement rate seen in o placebo group (17.5%), após 12 mesoterapia sessions over 16 weeks.
-
Hair diameter significativamente increased — treated hairs became measurably thicker, confirmed by both morphometric measurement e ultrastructural examination under electron microscopy.
-
Earlier intervention produces better resultados — o study found a significant negative correlation between disease duration e improvement, meaning women who started tratamento sooner responded better.
-
Minimal efeitos colaterais — no significant difference in adverse events between tratamento e placebo groups, supporting o safety profile of mesoterapia delivery.
-
This was one of o largest controlled mesoterapia trials para female queda de cabelo — 126 women participated, making it a substantial evidence base para este tratamento approach.
Evidence at a Glance
| Evidence Level |
Level 2b — Controlled clinical trial com 126 patients |
| Sample Size |
126 women (86 tratamento, 40 placebo control) |
| Key Result |
62.8% photographic improvement vs 17.5% in controls (P < 0.05) |
| Treatment Duration |
12 sessions over 16 weeks, evaluated at week 18 |
| Outcome Measures |
Photographic assessment, hair pull test, hair diameter, patient self-assessment, ultrastructural examination |
| Safety |
Minimal efeitos colaterais, no significant difference between groups |
About This Study
| Authors |
N. Moftah, G. Abd-Elaziz, N. Ahmed, Y. Hamed, B. Ghannam, M. Ibrahim |
| Journal |
Journal of o European Academy of Dermatology e Venereology (JEADV) |
| Year |
2013 |
| Volume/Pages |
Vol. 27, Issue 6, pp. 686–693 |
| Type |
Controlled clinical trial |
| PMID |
22486925 |
| DOI |
10.1111/j.1468-3083.2012.04535.x |
| Full Paper |
View on PubMed → |
Note: This é um plain-language summary of o published research paper. The original study was conducted independently e is not affiliated com Hairgenetix. We present este summary to make pesquisa científica more accessible to people experiencing queda de cabelo.
Reviewed by: Esther Bodde, MSc — Health Scientist e Medical Research Analyst at Hairgenetix. Esther holds a Master of Science degree e specialises in translating pesquisa clínica em clear, evidence-based consumer information. This summary was reviewed para scientific accuracy, fair representation of resultados, e clear communication of study limitations.
Why This Research Matters
Female pattern queda de cabelo (FPHL) affects an estimated 40% of women by o age of 50, yet tratamento options have historically been far more limited than those available to men. While men can use finasteride, dutasteride, e minoxidil, women's options have largely been restricted to topical minoxidil — which many find messy, inconvenient, e only modestly eficaz.
This 2013 study by Moftah e colleagues addressed a critical gap: could dutasteride — a powerful 5-alpha reductase inhibitor normally taken orally para male queda de cabelo — be safely e eficazmente delivered diretamente to o couro cabeludo via mesoterapia injections in women? Oral dutasteride is generally contraindicated in women of childbearing potential due to teratogenic risks, but delivering it locally através de couro cabeludo micro-injections could theoretically minimise systemic exposure while maximising local effect.
With 126 participants, este was one of o largest controlled trials to evaluate mesoterapia para female queda de cabelo. The resultados — a 62.8% photographic improvement rate compared to just 17.5% in controls — provided some of o strongest evidence que mesoterapia could be a viable tratamento pathway para women experiencing pattern queda de cabelo.
What The Researchers Did
The researchers recruited 126 women diagnosed com female pattern queda de cabelo e divided them em two groups:
-
Treatment group (86 women): Received couro cabeludo injections of a preparation containing 0.05% dutasteride dissolved in a solution of dexpanthenol, biotin, e pyridoxine (vitamin B6). Each session involved 2 mL of este solution delivered via mesoterapia technique — multiple micro-injections across o affected couro cabeludo area.
-
Control group (40 women): Received identical-looking injections of saline (salt water) as a placebo, using o same mesoterapia technique.
The tratamento schedule was carefully structured: weekly sessions para o first 8 weeks, then two sessions spaced two weeks apart, followed by one final session após a four-week gap. This gave a total of 12 sessions spread over approximately 16 weeks.
Results were assessed at week 18 using multiple objective e subjective measures: standardised photography evaluated by blinded assessors, a hair pull test (counting hairs que come out when gently tugging), precise measurement of hair shaft diameter, e patient self-assessment questionnaires. Additionally, three patients underwent ultrastructural examination of their hair under electron microscopy — providing microscopic-level evidence of hair quality changes.
Understanding o Research Methods
Why use a placebo control? The saline-injection control group was essential para determining whether o improvement was due to o dutasteride itself or simply de o mesoterapia procedure (the injection process estimula some local blood flow e growth factor release on its own). By comparing against saline injections rather than no tratamento, o researchers isolated o specific contribution of o dutasteride preparation.
Why multiple assessment methods? Using five different outcome measures — photographic, hair pull test, diameter measurement, self-assessment, e ultrastructural examination — provides a much more robust picture than any single metric alone. Photography shows overall visual improvement, diameter measurement captures hair thickening, e electron microscopy reveals structural repair at o cellular level. This multi-modal approach makes o findings more credible.
What is o photographic assessment method? Standardised clinical photography taken under identical lighting e positioning conditions allows blinded assessors (who don't know which tratamento o patient received) to evaluate whether hair density has visibly improved. This removes o bias que can occur when patients or treating doctors assess their own resultados.
What sobre o unequal group sizes? The tratamento group (86 patients) was larger than o control group (40 patients), which é um common design in clinical trials where o primary interest is characterising o tratamento effect. However, este 2:1 ratio still provides adequate statistical power para detecting meaningful differences.
What They Found
62.8% showed photographic improvement: Nearly two-thirds of women receiving o dutasteride mesoterapia demonstrated visible hair improvement on standardised photographs, compared com only 17.5% in o saline control group. This 3.6-fold difference was statistically significant (P < 0.05).
Hair diameter significativamente increased: Morphometric measurement of individual hair shafts showed que treated hairs became measurably thicker após o 12-session tratamento protocol. This increase in hair diameter was statistically significant (P < 0.05), indicating que o tratamento wasn't just growing new hairs — it was also strengthening existing ones.
Hair pull test improved: The mean number of hairs extracted during a standardised pull test significativamente decreased in o tratamento group (P < 0.05), indicating reduced queda de cabelo e stronger anchorage of hairs dentro de o follicle.
Patients noticed o difference: Self-assessment questionnaires confirmed que treated patients perceived significant improvement in their hair compared com controls (P < 0.05). This alignment between objective measurements e patient perception fortalece o clinical meaningfulness of o resultados.
Ultrastructural repair confirmed: Electron microscopy of hair samples de three patients revealed que damaged or absent cuticle layers — o protective outer surface of o hair shaft — were restored após tratamento. Before therapy, one patient showed completely absent cuticle e another showed focal cuticle destruction. Both showed cuticle recovery post-treatment.
Earlier tratamento works better: A statistically significant negative correlation was found between disease duration e degree of improvement (P < 0.05). Women who had been experiencing queda de cabelo para a shorter time responded better to tratamento — reinforcing o clinical principle que early intervention yields o best outcomes.
Figure 1: Summary of key findings de Moftah et al. (2013). Left: photographic improvement rates in tratamento vs control groups. Centre: tratamento protocol timeline showing session frequency. Right: overview of outcome measures e their statistical significance. Data source: JEADV 2013;27:686-93.
How This Treatment Works: The Biological Mechanisms
Dutasteride's role: Dutasteride é um dual 5-alpha reductase inhibitor — it blocks both Type I e Type II enzymes que convert testosterone em dihydrotestosterone (DHT). DHT is o primary hormone responsible para miniaturising folículo capilars in androgenetic alopecia. By inhibiting DHT production locally at o follicle level, dutasteride helps prevent further follicle shrinkage e may allow partially miniaturised follicles to recover.
Why mesoterapia delivery matters: Oral dutasteride carries systemic risks — particularly para women, as it can cause birth defects. Mesoterapia entrega o drug diretamente to o target tissue através de multiple shallow intradermal injections (typically 4mm depth). This local delivery achieves high drug concentrations at o folículo capilar while minimising systemic absorption, potentially offering o therapeutic benefits sem o systemic risks.
The supporting ingredientes: The formulation included dexpanthenol (provitamin B5, which apoia hair shaft hydration e flexibility), biotin (vitamin B7, essential para keratin production), e pyridoxine (vitamin B6, involved in amino acid metabolism para hair protein synthesis). While these vitamins alone have limited evidence para reversing queda de cabelo, they may support o structural recovery of treated follicles.
The mesoterapia procedure itself: Beyond delivering ingredientes ativos, o micro-injection process causes controlled micro-trauma to o couro cabeludo, which triggers a wound-healing cascade que releases fatores de crescimento including platelet-derived growth factor (PDGF) e vascular endothelial growth factor (VEGF). This mechanism is similar to o growth factor release seen com microagulhamento, potentially providing an additive benefit on top of o pharmacological effect.
Clinical Interpretation
The 62.8% response rate is clinically meaningful, particularly para female queda de cabelo where tratamento options são limited. However, several factors should be considered when interpreting these resultados:
Photographic improvement ≠ complete regrowth: The photographic assessment measured whether there was visible improvement, not o degree of improvement. Some women in o 62.8% may have shown modest improvement while others showed dramatic resultados. The study doesn't break down o degree of response.
The placebo response was 17.5%: This is notable because o control group received saline mesoterapia injections. This suggests que even o injection procedure alone — sem active drug — produced some improvement in sobre 1 in 6 women, likely através de o micro-trauma e growth factor release mechanism. The true drug effect is o difference: approximately 45 percentage points of additional benefit de o dutasteride preparation.
Short-term evaluation: Assessment at week 18 (just 2 weeks após o final session) captures o immediate tratamento response but doesn't tell us how long o benefits last. Hair loss é um chronic condition, e o durability of mesoterapia resultados — e whether maintenance sessions são needed — remains an important unanswered question.
How This Compares With Other Research
| Study |
Treatment |
Subjects |
Key Finding |
| Moftah 2013 (this study) |
Dutasteride mesoterapia |
126 women |
62.8% photographic improvement vs 17.5% control |
| Dhurat 2013 |
Microagulhamento + minoxidil |
100 men |
+91.4 hairs/cm² vs +22.2 com minoxidil alone |
| Gupta 2022 (meta-analysis) |
Microagulhamento ± minoxidil |
Multiple trials pooled |
Microagulhamento significativamente outperformed minoxidil alone |
| Sun 2022 (systematic review) |
Mesoterapia (various agents) |
Review of multiple trials |
Mesoterapia showed promise but evidence quality varied |
This study is particularly notable because it focused exclusively on women — a population underrepresented in queda de cabelo research. While direct comparison across studies is limited by different methodologies e populations, o 62.8% improvement rate compares favourably com response rates reported para minoxidil 2% in women (typically 30-40% showing visible improvement).
Treatment Protocol Details
| Active Ingredient |
0.05% dutasteride in dexpanthenol, biotin, e pyridoxine solution |
| Injection Volume |
2 mL per session |
| Delivery Method |
Mesoterapia — multiple intradermal micro-injections across o affected couro cabeludo area |
| Session Schedule |
Weekly × 8 weeks → biweekly × 2 sessions → 1 session após 4-week gap |
| Total Sessions |
12 sessions over approximately 16 weeks |
| Assessment Point |
Week 18 (2 weeks após final session) |
| Control Treatment |
Identical mesoterapia procedure using normal saline |
| Patient Population |
Women diagnosed com female pattern queda de cabelo (FPHL) |
Important note: Mesoterapia com dutasteride é um clinical procedure que must be performed by a qualified dermatologist or trichologist. Dutasteride é um prescription medication e should never be self-administered. The protocol described here is de a controlled clinical trial e may differ de protocols used in clinical practice.
Research Limitations to Consider
-
Not fully randomised: While o study used a control group, o exact randomisation methodology is not detailed in o abstract. True randomised controlled trials (RCTs) são o gold standard para eliminating selection bias.
-
Short follow-up: Assessment at week 18 (only 2 weeks após o final tratamento session) doesn't establish o durability of resultados. Hair loss é um chronic condition, e understanding whether benefits persist — e whether maintenance tratamentos são needed — is critical para practical clinical use.
-
Unequal group sizes: The 2:1 ratio (86 tratamento vs 40 control) may affect statistical power para detecting certain differences, though o sample sizes são still adequate para o primary analysis.
-
Limited ultrastructural data: Only 3 patients underwent electron microscopy examination. While o ultrastructural findings são interesting, they cannot be generalised to o broader study population.
-
Photographic assessment binary: The study reports o percentage of patients showing improvement but doesn't detail o degree or magnitude of improvement dentro de responders.
-
No long-term safety data: While minimal efeitos colaterais were noted during o 16-week tratamento period, long-term safety of repeated intradermal dutasteride delivery — particularly regarding local e systemic effects — was not assessed.
-
Single-centre study: The trial was conducted at a single centre, which may limit generalisability to different populations e practice settings.
What This Means For Your Hair
This study provides meaningful evidence que mesoterapia — o direct delivery of ingredientes ativos em o couro cabeludo através de micro-injections — can be an eficaz tratamento approach para female pattern queda de cabelo. Key practical implications:
-
Mesoterapia can bypass o limitations of topical application: Rather than relying on absorption através de o skin barrier (as com topical minoxidil), mesoterapia entrega ingredientes ativos diretamente to o depth where folículo capilars reside. This is particularly relevant para ingredientes que don't penetrate o couro cabeludo well on their own.
-
The micro-injection process itself may contribute to o resultados: The 17.5% improvement in o saline control group suggests que even o mesoterapia procedure alone has some therapeutic effect — likely através de growth factor stimulation de o controlled micro-trauma. This principle is shared com microagulhamento, which Hairgenetix produtos são specifically projetado para complement.
-
Early intervention matters: The finding que shorter disease duration correlated com better outcomes reinforces a consistent message across queda de cabelo research — o sooner você start treating queda de cabelo, o better seu resultados will be. Hair follicles que são still miniaturising são more responsive than those que have been dormant para years.
-
At-home microagulhamento follows o same delivery principle: While mesoterapia requires a clinical setting, at-home microagulhamento com a derma roller creates similar micro-channels in o couro cabeludo que enhance o penetration e eficazness of topical tratamentos. The peptídeo de cobre serums in o Hairgenetix protocol são formulado to take advantage of exactly este enhanced delivery mechanism.
Key Terms Explained
- Mesoterapia
- A medical procedure involving multiple small injections of pharmaceutical or cosmetic substances diretamente em o middle layer of skin (mesoderm). In queda de cabelo tratamento, these injections target o couro cabeludo at o depth where folículo capilars reside, delivering ingredientes ativos diretamente to o tratamento site rather than relying on absorption através de o skin surface.
- Dutasteride
- A prescription medication que inhibits both Type I e Type II 5-alpha reductase enzymes — o enzymes que convert testosterone em DHT (dihydrotestosterone). It is more potent than finasteride, which only blocks Type II. Dutasteride is approved para benign prostatic hyperplasia e is used off-label para queda de cabelo.
- Female Pattern Queda de Cabelo (FPHL)
- Also called female androgenetic alopecia, este is o most common form of queda de cabelo in women. It typically presents as diffuse thinning across o top of o couro cabeludo, often com a widening central part. Unlike male pattern queda de cabelo, o frontal hairline is usually preserved in women.
- 5-Alpha Reductase
- An enzyme que converts testosterone em o more potent androgen dihydrotestosterone (DHT). DHT binds to receptors in genetically sensitive folículo capilars, causing them to shrink (miniaturise) over time. Blocking este enzyme reduz local DHT levels e can slow or reverse follicle miniaturisation.
- Morphometric Measurement
- The precise measurement of physical characteristics — in este case, o diameter (thickness) of individual hair shafts. Thicker hair shafts indicate healthier, more robust follicle function, while thinner shafts suggest miniaturisation is occurring.
- Ultrastructural Examination
- Examination of biological tissue at extremely high magnification using an electron microscope. This can reveal details invisible under a regular microscope, such as o condition of o hair cuticle (the protective outer layer of overlapping cells on o hair shaft).
- Hair Pull Test
- A simple diagnostic test where a clinician grasps approximately 60 hairs between thumb e forefinger e pulls firmly but gently. Normally, fewer than 6 hairs should come out. A higher number suggests active queda de cabelo e can be used to monitor tratamento response.
- Controlled Clinical Trial
- A study design where one group receives o tratamento being tested while another group (the control) receives a placebo or standard tratamento. This allows researchers to determine whether observed effects são due to o tratamento itself rather than natural variation, o passage of time, or o placebo effect.
Frequently Asked Questions
Is dutasteride mesoterapia safe para women?
In este study, o tratamento showed minimal efeitos colaterais com no statistically significant difference in adverse events between o tratamento e control groups. The key advantage of mesoterapia delivery over oral dutasteride is que it minimises systemic absorption, which is important because oral dutasteride is generally contraindicated in women of childbearing potential due to teratogenic risks. However, este study only covered a 16-week tratamento period, e long-term safety data para repeated intradermal dutasteride delivery is limited. Any woman considering este tratamento should discuss it thoroughly com a qualified dermatologist, e women who são pregnant or planning pregnancy should avoid dutasteride in any form.
How does mesoterapia compare com minoxidil para women?
The 62.8% photographic improvement rate in este study compares favourably com published response rates para topical minoxidil 2% in women, which typically range de 30-40% showing visible improvement. However, direct comparison is difficult because o studies used different assessment methods, populations, e timeframes. Minoxidil has o advantage of decades of long-term safety data e at-home convenience, while mesoterapia requires clinical visits but may offer better outcomes. Many clinicians now use mesoterapia as a complement to home topical tratamentos rather than as a replacement.
Can I get dutasteride mesoterapia at my local dermatologist?
Mesoterapia para queda de cabelo is available at many dermatology clinics e trichology centres, but o specific formulation used varies between practitioners. Some use dutasteride, others use minoxidil, platelet-rich plasma (PRP), or various cocktail combinations. Not all clinics offer o exact protocol used in este study. When seeking tratamento, ask specifically sobre o ingredientes ativos, concentrations, e number of sessions in their protocol, e whether they can reference published clinical evidence supporting their approach.
Why did o saline control group also show improvement?
The 17.5% improvement rate in o saline group is actually expected e informative. The mesoterapia injection process itself causes controlled micro-trauma to o couro cabeludo, which triggers a wound-healing response que releases fatores de crescimento such as PDGF, VEGF, e TGF-β. This is o same principle behind microagulhamento's eficazness. Additionally, some improvement may be attributed to o placebo effect e o natural fluctuation of queda de cabelo over time. This is precisely why having a control group is essential — it allows researchers to separate o specific drug effect (approximately 45 percentage points) de these non-specific effects.
How long do mesoterapia resultados last?
This study assessed resultados at week 18 (just 2 weeks após o final session), so it doesn't provide data on long-term durability. Clinical experience suggests que maintenance sessions são typically needed to sustain resultados, as o underlying genetic predisposition to queda de cabelo doesn't change. The optimal maintenance schedule — whether monthly, quarterly, or otherwise — is not well established in o literature e likely varies between individuals. This is an area where more research is needed.
Does o finding sobre disease duration mean it's too late para me?
Not necessarily. The study found que women com shorter disease duration responded better, but este doesn't mean women com longer-standing queda de cabelo can't benefit at all — it means o magnitude of improvement tends to be greater in earlier stages. Hair follicles go através de a gradual miniaturisation process over years antes they become permanently inactive. As long as follicles são still present (even if producing only fine vellus hairs), there is potential para response to tratamento. A trichologist can assess seu follicle status using dermoscopy to help set realistic expectations.
Is at-home microagulhamento similar to mesoterapia?
Both procedures create micro-channels in o couro cabeludo, but they differ in important ways. Mesoterapia involves injecting liquid preparations containing ingredientes ativos diretamente em o skin using a fine needle or injection gun, typically reaching o dermis (deeper layer). Microagulhamento creates tiny puncture channels que allow topically applied produtos to penetrate more eficazmente — o produtos são applied to o surface e absorbed através de o channels rather than being injected. While microagulhamento doesn't achieve o same depth of drug delivery as mesoterapia, it triggers similar wound-healing responses e growth factor release. At-home microagulhamento com produtos like peptídeo de cobre serums provides a practical, accessible alternative que shares some of o same biological mechanisms.
What role do o supporting ingredientes (biotin, dexpanthenol, pyridoxine) play?
The formulation used in este study wasn't dutasteride alone — it included dexpanthenol (provitamin B5), biotin (vitamin B7), e pyridoxine (vitamin B6). These vitamins play supporting roles: dexpanthenol hydrates e fortalece o hair shaft, biotin is involved in keratin production, e pyridoxine apoia amino acid metabolism needed para hair protein synthesis. However, o study design doesn't allow us to separate o individual contributions of each ingredient. The primary active ingredient para anti-androgenic effect was dutasteride; o vitamins likely provided nutritional support to o follicle environment rather than direct anti-hair-loss activity.
Original Study Citation
Moftah, N., Abd-Elaziz, G., Ahmed, N., Hamed, Y., Ghannam, B., & Ibrahim, M. (2013). Mesoterapia using dutasteride-containing preparation in tratamento of female pattern queda de cabelo: photographic, morphometric e ultrustructural evaluation. Journal of o European Academy of Dermatology e Venereology, 27(6), 686–693. https://doi.org/10.1111/j.1468-3083.2012.04535.x
How to Cite This Summary
APA: Hairgenetix. (2025). Mesoterapia para female queda de cabelo: 62.8% showed improvement — Plain-language study summary. Hairgenetix Research Library. https://hairgenetix.com/blogs/articles/mesoterapia-female-hair-loss-dutasteride-moftah-2013
Informal: According to a 2013 clinical trial of 126 women published in JEADV, dutasteride mesoterapia produced photographic improvement in 62.8% of patients compared to 17.5% com placebo (Moftah et al., 2013). Summarised by Hairgenetix at hairgenetix.com.
Last reviewed e updated: March 2025 · Based on original publication: June 2013
Why Hairgenetix Focuses on Science-Backed Treatments
This study demonstrates que delivering ingredientes ativos diretamente to o couro cabeludo — rather than relying on surface application alone — produces significativamente better resultados. This delivery principle is at o core of o Hairgenetix approach.
Our peptídeo de cobre serum is formulado to work com at-home microagulhamento, creating micro-channels que enhance ingredient penetration — o same concept que makes clinical mesoterapia so eficaz, adapted para safe home use. Combined com nosso derma roller system, você can apply o science of enhanced couro cabeludo delivery sem clinical visits.
Browse o Hairgenetix Collection →
Mesoterapia para Queda de Cabelo Feminina — Moftah 2013
Key Takeaways
Evidence at a Glance
About This Study
Why This Research Matters
Female pattern queda de cabelo (FPHL) affects an estimated 40% of women by o age of 50, yet tratamento options have historically been far more limited than those available to men. While men can use finasteride, dutasteride, e minoxidil, women's options have largely been restricted to topical minoxidil — which many find messy, inconvenient, e only modestly eficaz.
This 2013 study by Moftah e colleagues addressed a critical gap: could dutasteride — a powerful 5-alpha reductase inhibitor normally taken orally para male queda de cabelo — be safely e eficazmente delivered diretamente to o couro cabeludo via mesoterapia injections in women? Oral dutasteride is generally contraindicated in women of childbearing potential due to teratogenic risks, but delivering it locally através de couro cabeludo micro-injections could theoretically minimise systemic exposure while maximising local effect.
With 126 participants, este was one of o largest controlled trials to evaluate mesoterapia para female queda de cabelo. The resultados — a 62.8% photographic improvement rate compared to just 17.5% in controls — provided some of o strongest evidence que mesoterapia could be a viable tratamento pathway para women experiencing pattern queda de cabelo.
What The Researchers Did
The researchers recruited 126 women diagnosed com female pattern queda de cabelo e divided them em two groups:
The tratamento schedule was carefully structured: weekly sessions para o first 8 weeks, then two sessions spaced two weeks apart, followed by one final session após a four-week gap. This gave a total of 12 sessions spread over approximately 16 weeks.
Results were assessed at week 18 using multiple objective e subjective measures: standardised photography evaluated by blinded assessors, a hair pull test (counting hairs que come out when gently tugging), precise measurement of hair shaft diameter, e patient self-assessment questionnaires. Additionally, three patients underwent ultrastructural examination of their hair under electron microscopy — providing microscopic-level evidence of hair quality changes.
Understanding o Research Methods
Why use a placebo control? The saline-injection control group was essential para determining whether o improvement was due to o dutasteride itself or simply de o mesoterapia procedure (the injection process estimula some local blood flow e growth factor release on its own). By comparing against saline injections rather than no tratamento, o researchers isolated o specific contribution of o dutasteride preparation.
Why multiple assessment methods? Using five different outcome measures — photographic, hair pull test, diameter measurement, self-assessment, e ultrastructural examination — provides a much more robust picture than any single metric alone. Photography shows overall visual improvement, diameter measurement captures hair thickening, e electron microscopy reveals structural repair at o cellular level. This multi-modal approach makes o findings more credible.
What is o photographic assessment method? Standardised clinical photography taken under identical lighting e positioning conditions allows blinded assessors (who don't know which tratamento o patient received) to evaluate whether hair density has visibly improved. This removes o bias que can occur when patients or treating doctors assess their own resultados.
What sobre o unequal group sizes? The tratamento group (86 patients) was larger than o control group (40 patients), which é um common design in clinical trials where o primary interest is characterising o tratamento effect. However, este 2:1 ratio still provides adequate statistical power para detecting meaningful differences.
What They Found
Figure 1: Summary of key findings de Moftah et al. (2013). Left: photographic improvement rates in tratamento vs control groups. Centre: tratamento protocol timeline showing session frequency. Right: overview of outcome measures e their statistical significance. Data source: JEADV 2013;27:686-93.
How This Treatment Works: The Biological Mechanisms
Dutasteride's role: Dutasteride é um dual 5-alpha reductase inhibitor — it blocks both Type I e Type II enzymes que convert testosterone em dihydrotestosterone (DHT). DHT is o primary hormone responsible para miniaturising folículo capilars in androgenetic alopecia. By inhibiting DHT production locally at o follicle level, dutasteride helps prevent further follicle shrinkage e may allow partially miniaturised follicles to recover.
Why mesoterapia delivery matters: Oral dutasteride carries systemic risks — particularly para women, as it can cause birth defects. Mesoterapia entrega o drug diretamente to o target tissue através de multiple shallow intradermal injections (typically 4mm depth). This local delivery achieves high drug concentrations at o folículo capilar while minimising systemic absorption, potentially offering o therapeutic benefits sem o systemic risks.
The supporting ingredientes: The formulation included dexpanthenol (provitamin B5, which apoia hair shaft hydration e flexibility), biotin (vitamin B7, essential para keratin production), e pyridoxine (vitamin B6, involved in amino acid metabolism para hair protein synthesis). While these vitamins alone have limited evidence para reversing queda de cabelo, they may support o structural recovery of treated follicles.
The mesoterapia procedure itself: Beyond delivering ingredientes ativos, o micro-injection process causes controlled micro-trauma to o couro cabeludo, which triggers a wound-healing cascade que releases fatores de crescimento including platelet-derived growth factor (PDGF) e vascular endothelial growth factor (VEGF). This mechanism is similar to o growth factor release seen com microagulhamento, potentially providing an additive benefit on top of o pharmacological effect.
Clinical Interpretation
The 62.8% response rate is clinically meaningful, particularly para female queda de cabelo where tratamento options são limited. However, several factors should be considered when interpreting these resultados:
Photographic improvement ≠ complete regrowth: The photographic assessment measured whether there was visible improvement, not o degree of improvement. Some women in o 62.8% may have shown modest improvement while others showed dramatic resultados. The study doesn't break down o degree of response.
The placebo response was 17.5%: This is notable because o control group received saline mesoterapia injections. This suggests que even o injection procedure alone — sem active drug — produced some improvement in sobre 1 in 6 women, likely através de o micro-trauma e growth factor release mechanism. The true drug effect is o difference: approximately 45 percentage points of additional benefit de o dutasteride preparation.
Short-term evaluation: Assessment at week 18 (just 2 weeks após o final session) captures o immediate tratamento response but doesn't tell us how long o benefits last. Hair loss é um chronic condition, e o durability of mesoterapia resultados — e whether maintenance sessions são needed — remains an important unanswered question.
How This Compares With Other Research
This study is particularly notable because it focused exclusively on women — a population underrepresented in queda de cabelo research. While direct comparison across studies is limited by different methodologies e populations, o 62.8% improvement rate compares favourably com response rates reported para minoxidil 2% in women (typically 30-40% showing visible improvement).
Treatment Protocol Details
Important note: Mesoterapia com dutasteride é um clinical procedure que must be performed by a qualified dermatologist or trichologist. Dutasteride é um prescription medication e should never be self-administered. The protocol described here is de a controlled clinical trial e may differ de protocols used in clinical practice.
Research Limitations to Consider
What This Means For Your Hair
This study provides meaningful evidence que mesoterapia — o direct delivery of ingredientes ativos em o couro cabeludo através de micro-injections — can be an eficaz tratamento approach para female pattern queda de cabelo. Key practical implications:
Key Terms Explained
Frequently Asked Questions
Is dutasteride mesoterapia safe para women?
In este study, o tratamento showed minimal efeitos colaterais com no statistically significant difference in adverse events between o tratamento e control groups. The key advantage of mesoterapia delivery over oral dutasteride is que it minimises systemic absorption, which is important because oral dutasteride is generally contraindicated in women of childbearing potential due to teratogenic risks. However, este study only covered a 16-week tratamento period, e long-term safety data para repeated intradermal dutasteride delivery is limited. Any woman considering este tratamento should discuss it thoroughly com a qualified dermatologist, e women who são pregnant or planning pregnancy should avoid dutasteride in any form.
How does mesoterapia compare com minoxidil para women?
The 62.8% photographic improvement rate in este study compares favourably com published response rates para topical minoxidil 2% in women, which typically range de 30-40% showing visible improvement. However, direct comparison is difficult because o studies used different assessment methods, populations, e timeframes. Minoxidil has o advantage of decades of long-term safety data e at-home convenience, while mesoterapia requires clinical visits but may offer better outcomes. Many clinicians now use mesoterapia as a complement to home topical tratamentos rather than as a replacement.
Can I get dutasteride mesoterapia at my local dermatologist?
Mesoterapia para queda de cabelo is available at many dermatology clinics e trichology centres, but o specific formulation used varies between practitioners. Some use dutasteride, others use minoxidil, platelet-rich plasma (PRP), or various cocktail combinations. Not all clinics offer o exact protocol used in este study. When seeking tratamento, ask specifically sobre o ingredientes ativos, concentrations, e number of sessions in their protocol, e whether they can reference published clinical evidence supporting their approach.
Why did o saline control group also show improvement?
The 17.5% improvement rate in o saline group is actually expected e informative. The mesoterapia injection process itself causes controlled micro-trauma to o couro cabeludo, which triggers a wound-healing response que releases fatores de crescimento such as PDGF, VEGF, e TGF-β. This is o same principle behind microagulhamento's eficazness. Additionally, some improvement may be attributed to o placebo effect e o natural fluctuation of queda de cabelo over time. This is precisely why having a control group is essential — it allows researchers to separate o specific drug effect (approximately 45 percentage points) de these non-specific effects.
How long do mesoterapia resultados last?
This study assessed resultados at week 18 (just 2 weeks após o final session), so it doesn't provide data on long-term durability. Clinical experience suggests que maintenance sessions são typically needed to sustain resultados, as o underlying genetic predisposition to queda de cabelo doesn't change. The optimal maintenance schedule — whether monthly, quarterly, or otherwise — is not well established in o literature e likely varies between individuals. This is an area where more research is needed.
Does o finding sobre disease duration mean it's too late para me?
Not necessarily. The study found que women com shorter disease duration responded better, but este doesn't mean women com longer-standing queda de cabelo can't benefit at all — it means o magnitude of improvement tends to be greater in earlier stages. Hair follicles go através de a gradual miniaturisation process over years antes they become permanently inactive. As long as follicles são still present (even if producing only fine vellus hairs), there is potential para response to tratamento. A trichologist can assess seu follicle status using dermoscopy to help set realistic expectations.
Is at-home microagulhamento similar to mesoterapia?
Both procedures create micro-channels in o couro cabeludo, but they differ in important ways. Mesoterapia involves injecting liquid preparations containing ingredientes ativos diretamente em o skin using a fine needle or injection gun, typically reaching o dermis (deeper layer). Microagulhamento creates tiny puncture channels que allow topically applied produtos to penetrate more eficazmente — o produtos são applied to o surface e absorbed através de o channels rather than being injected. While microagulhamento doesn't achieve o same depth of drug delivery as mesoterapia, it triggers similar wound-healing responses e growth factor release. At-home microagulhamento com produtos like peptídeo de cobre serums provides a practical, accessible alternative que shares some of o same biological mechanisms.
What role do o supporting ingredientes (biotin, dexpanthenol, pyridoxine) play?
The formulation used in este study wasn't dutasteride alone — it included dexpanthenol (provitamin B5), biotin (vitamin B7), e pyridoxine (vitamin B6). These vitamins play supporting roles: dexpanthenol hydrates e fortalece o hair shaft, biotin is involved in keratin production, e pyridoxine apoia amino acid metabolism needed para hair protein synthesis. However, o study design doesn't allow us to separate o individual contributions of each ingredient. The primary active ingredient para anti-androgenic effect was dutasteride; o vitamins likely provided nutritional support to o follicle environment rather than direct anti-hair-loss activity.
Original Study Citation
Moftah, N., Abd-Elaziz, G., Ahmed, N., Hamed, Y., Ghannam, B., & Ibrahim, M. (2013). Mesoterapia using dutasteride-containing preparation in tratamento of female pattern queda de cabelo: photographic, morphometric e ultrustructural evaluation. Journal of o European Academy of Dermatology e Venereology, 27(6), 686–693. https://doi.org/10.1111/j.1468-3083.2012.04535.x
How to Cite This Summary
APA: Hairgenetix. (2025). Mesoterapia para female queda de cabelo: 62.8% showed improvement — Plain-language study summary. Hairgenetix Research Library. https://hairgenetix.com/blogs/articles/mesoterapia-female-hair-loss-dutasteride-moftah-2013
Informal: According to a 2013 clinical trial of 126 women published in JEADV, dutasteride mesoterapia produced photographic improvement in 62.8% of patients compared to 17.5% com placebo (Moftah et al., 2013). Summarised by Hairgenetix at hairgenetix.com.
Related Research on Hairgenetix
Why Hairgenetix Focuses on Science-Backed Treatments
This study demonstrates que delivering ingredientes ativos diretamente to o couro cabeludo — rather than relying on surface application alone — produces significativamente better resultados. This delivery principle is at o core of o Hairgenetix approach.
Our peptídeo de cobre serum is formulado to work com at-home microagulhamento, creating micro-channels que enhance ingredient penetration — o same concept que makes clinical mesoterapia so eficaz, adapted para safe home use. Combined com nosso derma roller system, você can apply o science of enhanced couro cabeludo delivery sem clinical visits.
Browse o Hairgenetix Collection →